Controlled drug delivery systems have revolutionized pharmaceutical sciences by enabling precise modulation of drug release, improved therapeutic efficacy, and reduced adverse effects. Conventional dosage forms often exhibit limitations such as fluctuating plasma concentrations, poor patient compliance, and suboptimal bioavailability. In response to these challenges, extensive research has been conducted to develop advanced drug delivery platforms capable of achieving sustained, targeted, and controlled release profiles. Among these, multiple emulsions, matrix-based sustained release formulations, lipid-based nanoparticles, and nanostructured lipid carriers have emerged as highly promising technologies. The present research article provides a comprehensive theoretical exploration of modern controlled drug delivery systems with a particular focus on lipid-based nanocarriers and their potential application in the delivery of antipsychotic drugs such as ziprasidone. The work integrates foundational concepts of biopharmaceutics and pharmacokinetics with contemporary developments in nanotechnology and pharmaceutical formulation science.

This study synthesizes information from a wide body of scientific literature to examine the design principles, physicochemical characteristics, release mechanisms, and therapeutic advantages of advanced drug delivery systems. Special attention is devoted to the formulation strategies employed in nanostructured lipid carriers, multiple emulsions, and polymer-based matrices, along with their influence on drug stability, biodistribution, and pharmacokinetic behavior. Furthermore, the pharmacological profile of ziprasidone, an atypical antipsychotic used in the management of schizophrenia and related psychiatric disorders, is analyzed to highlight the relevance of controlled drug delivery in improving treatment adherence and therapeutic outcomes.

The findings reveal that advanced lipid-based and nanoparticle-based systems significantly enhance drug encapsulation efficiency, controlled release behavior, and targeted delivery potential. These systems also demonstrate the ability to overcome biological barriers and evade rapid clearance by the reticuloendothelial system, thereby prolonging systemic circulation time. The discussion emphasizes the clinical implications of these technologies, their limitations, and future prospects in precision medicine and personalized pharmacotherapy. The article concludes that continued integration of nanotechnology, polymer science, and pharmacokinetics will play a critical role in shaping the next generation of drug delivery platforms.

Controlled drug delivery, nanostructured lipid carriers, multiple emulsions, sustained release systems, ziprasidone, nanotechnology, pharmacokinetics

Abdel-Rahman SI, Mahrous GM, El-Badry M. Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharmaceutical Journal.

Bernheim KF, Lewine RR. Schizophrenia: Symptoms, causes and treatments. Medical Anthropology Newsletter.

Bharadwaj S. Bio-degradable parenteral depot system: A best approach of controlled release. Latest Reviews.

Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: A Treatise. Vallabh Prakashan.

Caley CF, Cooper CK. Ziprasidone: The fifth atypical antipsychotic. The Annals of Pharmacotherapy.

Chen C, Tsai T, Huang Z, Fang J. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers. European Journal of Pharmaceutics and Biopharmaceutics.

Chudasama JD, Channabasavaraj KP, Pandya CB, Mani TT. Development and validation of a rapid RP-HPLC method for the estimation of ziprasidone hydrochloride monohydrate. International Journal of Pharmaceutical Sciences Review and Research.

Elbe D, Carandang CG. Focus on ziprasidone: A review of its use in child and adolescent psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry.

Florence AT, Whitehill D. The formulation and stability of multiple emulsions. International Journal of Pharmaceutics.

Gaur U, Sahoo SK, Ghosh PC, Maitra A, Ghosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. International Journal of Pharmaceutics.

Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences.

Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Industrial and Engineering Chemistry.

Kasongo KW, Shegokar R, Müller RH, Walker RB. Formulation development and in-vitro evaluation of didanosine-loaded nanostructured lipid carriers. Drug Development and Industrial Pharmacy.

Lee VH, Robinson JR. Sustained and Controlled Release Drug Delivery Systems. Marcel Dekker.

Meng R, Wu Z, Xie QT, Cheng JS, Zhang B. Preparation and characterization of zein/carboxymethyl dextrin nanoparticles to encapsulate curcumin. Food Chemistry.

Miceli J, Wilner K, Hansen R, Johnson A, Apseloff G, Gerber N. Single and multiple dose pharmacokinetics of ziprasidone under non-fasting conditions. British Journal of Clinical Pharmacology.

Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. International Journal of Pharmaceutics.

Omotosho JA. The effect of acacia, gelatin and polyvinylpyrrolidone on chloroquine transport from multiple emulsions. International Journal of Pharmaceutics.

Park H, Otte A, Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. Journal of Controlled Release.

Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MP, Acosta-Torres LS, Shin HS. Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology.

Perkins DO. Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry.

Pham DT, Tiyaboonchai W. Fibroin nanoparticles: A promising drug delivery system. Drug Delivery.

Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-based nanoparticles for drug delivery systems. Characterization and Biology of Nanomaterials for Drug Delivery.

Selvamuthukumar S, Velmurugan R. Nanostructured lipid carriers: A potential drug carrier for cancer chemotherapy. Lipids in Health and Disease.

Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose. Advanced Drug Delivery Reviews.

Sinha VR, Kumar A. Multiple emulsions: An overview of formulation, characterization, stability and applications. Indian Journal of Pharmaceutical Sciences.

Xu G, Sunada H. Influence of formulation change on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Chemical and Pharmaceutical Bulletin.